Rubrofusarin-6-β-gentiobioside inhibits lipid accumulation and weight gain by regulating AMPK/mTOR signaling

ConclusionRFG can ameliorate obesity, and thus, could be used as a therapeutic agent for treating obesity.Graphical abstract
Source: Phytomedicine - Category: Drugs & Pharmacology Source Type: research